These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17214957)

  • 1. Identification of a highly potent vitamin D receptor antagonist: (25S)-26-adamantyl-25-hydroxy-2-methylene-22,23-didehydro-19,27-dinor-20-epi-vitamin D3 (ADMI3).
    Igarashi M; Yoshimoto N; Yamamoto K; Shimizu M; Ishizawa M; Makishima M; DeLuca HF; Yamada S
    Arch Biochem Biophys; 2007 Apr; 460(2):240-53. PubMed ID: 17214957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 22-Alkyl-20-epi-1alpha,25-dihydroxyvitamin D3 compounds of superagonistic activity: syntheses, biological activities and interaction with the receptor.
    Yamamoto K; Inaba Y; Yoshimoto N; Choi M; DeLuca HF; Yamada S
    J Med Chem; 2007 Mar; 50(5):932-9. PubMed ID: 17298045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological activities of new 1alpha,25-dihydroxy-19-norvitamin D3 analogs with modifications in both the A-ring and the side chain.
    Shimizu M; Miyamoto Y; Kobayashi E; Shimazaki M; Yamamoto K; Reischl W; Yamada S
    Bioorg Med Chem; 2006 Jun; 14(12):4277-94. PubMed ID: 16503143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel 1alpha,25-dihydroxyvitamin D3 analogues with the side chain at C12.
    González-Avión XC; Mouriño A; Rochel N; Moras D
    J Med Chem; 2006 Mar; 49(5):1509-16. PubMed ID: 16509569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New 1alpha,25-dihydroxy-19-norvitamin D3 compounds of high biological activity: synthesis and biological evaluation of 2-hydroxymethyl, 2-methyl, and 2-methylene analogues.
    Sicinski RR; Prahl JM; Smith CM; DeLuca HF
    J Med Chem; 1998 Nov; 41(23):4662-74. PubMed ID: 9804706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, Biological Activities, and X-ray Crystal Structural Analysis of 25-Hydroxy-25(or 26)-adamantyl-17-[20(22),23-diynyl]-21-norvitamin D Compounds.
    Watarai Y; Ishizawa M; Ikura T; Zacconi FC; Uno S; Ito N; Mouriño A; Tokiwa H; Makishima M; Yamada S
    J Med Chem; 2015 Dec; 58(24):9510-21. PubMed ID: 26613420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New derivatives of 1alpha,25-dihydroxy-19-norvitamin D3 with two substituents at C-2: synthesis and biological activity.
    Shimizu M; Iwasaki Y; Shimazaki M; Amano Y; Yamamoto K; Reischl W; Yamada S
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1451-5. PubMed ID: 15713405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships of 19-norvitamin D analogs having a fluoroethylidene group at the C-2 position.
    Kobayashi E; Shimazaki M; Miyamoto Y; Masuno H; Yamamoto K; DeLuca HF; Yamada S; Shimizu M
    Bioorg Med Chem; 2007 Feb; 15(3):1475-82. PubMed ID: 17110116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superagonistic action of 14-epi-analogs of 1,25-dihydroxyvitamin D explained by vitamin D receptor-coactivator interaction.
    Eelen G; Verlinden L; Rochel N; Claessens F; De Clercq P; Vandewalle M; Tocchini-Valentini G; Moras D; Bouillon R; Verstuyf A
    Mol Pharmacol; 2005 May; 67(5):1566-73. PubMed ID: 15728261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 13-Methyl-substituted des-C,D analogs of (20S)-1alpha,25-dihydroxy-2-methylene-19-norvitamin D3 (2MD): synthesis and biological evaluation.
    Plonska-Ocypa K; Sicinski RR; Plum LA; Grzywacz P; Frelek J; Clagett-Dame M; DeLuca HF
    Bioorg Med Chem; 2009 Feb; 17(4):1747-63. PubMed ID: 19167893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Methylene 19-nor-25-dehydro-1alpha-hydroxyvitamin D3 26,23-lactones: synthesis, biological activities and molecular basis of passive antagonism.
    Yoshimoto N; Inaba Y; Yamada S; Makishima M; Shimizu M; Yamamoto K
    Bioorg Med Chem; 2008 Jan; 16(1):457-73. PubMed ID: 17904370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New derivative of 1alpha,25-dihydroxy-19-norvitamin D3 with 3'-alkoxypropylidene moiety at C-2: synthesis, biological activity and conformational analysis.
    Glebocka A; Sicinski RR; DeLuca HF
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):25-30. PubMed ID: 15225741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Methylene analogs of 1alpha-hydroxy-19-norvitamin D3: synthesis, biological activities and docking to the ligand binding domain of the rat vitamin D receptor.
    Grzywacz P; Plum LA; Sicinska W; Sicinski RR; Prahl JM; DeLuca HF
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):13-7. PubMed ID: 15225739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Methylene-19-nor-1alpha-hydroxyvitamin D3 analogs inhibit adipocyte differentiation and PPARgamma2 gene transcription.
    Thomson B; Ahrens JM; Ntambi JM; DeLuca HF; Clagett-Dame M
    Arch Biochem Biophys; 2007 Apr; 460(2):192-201. PubMed ID: 17257576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analogs of 1alpha,25-dihydroxyvitamin D3 with high potency in induction of osteoclastogenesis and prevention of dendritic cell differentiation: synthesis and biological evaluation of 2-substituted 19-norvitamin D analogs.
    Shimazaki M; Miyamoto Y; Yamamoto K; Yamada S; Takami M; Shinki T; Udagawa N; Shimizu M
    Bioorg Med Chem; 2006 Jul; 14(13):4645-56. PubMed ID: 16513359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel 2-alkyl-1alpha,25-dihydroxy-19-norvitamin D3: efficient synthesis with Julia olefination, evaluation of biological activity and development of new analyzing system for co-activator recruitment.
    Arai MA; Kittaka A
    Anticancer Res; 2006; 26(4A):2621-31. PubMed ID: 16886672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure-activity relationships of 16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs having side chains of different sizes.
    Takaku H; Miyamoto Y; Asami S; Shimazaki M; Yamada S; Yamamoto K; Udagawa N; DeLuca HF; Shimizu M
    Bioorg Med Chem; 2008 Feb; 16(4):1796-815. PubMed ID: 18032055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structures of rat vitamin D receptor bound to adamantyl vitamin D analogs: structural basis for vitamin D receptor antagonism and partial agonism.
    Nakabayashi M; Yamada S; Yoshimoto N; Tanaka T; Igarashi M; Ikura T; Ito N; Makishima M; Tokiwa H; DeLuca HF; Shimizu M
    J Med Chem; 2008 Sep; 51(17):5320-9. PubMed ID: 18710208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practical synthesis and evaluation of the biological activities of 1alpha,25-dihydroxyvitamin D3 antagonists, 1alpha,25-dihydroxyvitamin D3-26,23-lactams. Designed on the basis of the helix 12-folding inhibition hypothesis.
    Nakano Y; Kato Y; Imai K; Ochiai E; Namekawa J; Ishizuka S; Takenouchi K; Tanatani A; Hashimoto Y; Nagasawa K
    J Med Chem; 2006 Apr; 49(8):2398-406. PubMed ID: 16610783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further synthetic and biological studies on vitamin D hormone antagonists based on C24-alkylation and C2alpha-functionalization of 25-dehydro-1alpha-hydroxyvitamin D(3)-26,23-lactones.
    Saito N; Matsunaga T; Saito H; Anzai M; Takenouchi K; Miura D; Namekawa J; Ishizuka S; Kittaka A
    J Med Chem; 2006 Nov; 49(24):7063-75. PubMed ID: 17125259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.